- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT01964274
Relevance of the Peripheral Cholinesterase-activity on Neurocognitive Dysfunctions in Surgical Patients (CESARO)
In this prospective, multicenter observational study the investigators capture the perioperative course of peripheral cholinesterase activity. The focus is the perioperative inflammation causing postoperative delirium. Therefore we measure the activity of Acetylcholine-Esterase and Butyrylcholine-Esterase in whole blood of adults in the perioperative context. Early postoperative delirium will be detected by Nu-DESC in the Recovery Room or the Postanaesthesia-Care-Unit. The course of the peripheral cholinesterase activity will be compared with the incidence of postoperative delirium and other clinical dysfunctions.
We follow up the patients for up to five years regarding Delirum, comorbidities and mortality data.
Tutkimuksen yleiskatsaus
Tila
Opintotyyppi
Ilmoittautuminen (Todellinen)
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
Berlin, Saksa, 13353
- Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin
-
Berlin, Saksa, 14129
- Department of Anesthesia, Klinik für MIC
-
Bochum, Saksa, 44789
- Clinic for Anaesthesiology, Intensive Care Medicine, Palliative Medicine and Pain Medicine, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil
-
Heidelberg, Saksa, 69120
- Department of Anesthesiology, Universitätsklinikum Heidelberg
-
München, Saksa, 81377
- Department of Anesthesiology, Klinikum Großhadern of the Ludwig Maximilians University of Munich
-
Regensburg, Saksa, 93053
- Department of Anesthesiology, Universitätsklinikum Regensburg
-
Ulm, Saksa, 89081
- Department of Anesthesiology, Universitätsklinikum Ulm
-
Wetzlar, Saksa, 35578
- Department of Anesthesiology and Intensive Care Medicine
-
Würzburg, Saksa, 97080
- Department of Anaesthesia and Critical Care, Universitätsklinikum Würzburg
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Näytteenottomenetelmä
Tutkimusväestö
Kuvaus
Inclusion Criteria:
- Male and female patients with age 18 years and above scheduled for surgery with planned stay in Recovery Room or Postanesthesia-Care-Unit
- Offered patient information and written informed consent
- In-hospital stay for at least 24 hours
Exclusion Criteria:
- Patients with known pseudocholinesterase deficiency
- Participation in prospective intervention studies during the study period
- Analphabetism
- Unability of German and English language use
- Anacusis or Hypoacusis with hearing aid device, Amaurosis
- Lacking willingness to save and hand out data within the study
- Accommodation in an institution due to an official or judicial order
- Coworker of the clinic (study center)
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
Kohortit ja interventiot
Ryhmä/Kohortti |
|---|
|
Surgical patients
Adult male and female patients undergoing surgery
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Postoperative Delirium
Aikaikkuna: Participants will be followed in the sample period, an exspected average of three days
|
Postoperative Delirium (measured by Nursing Delirium Screening Scale)
|
Participants will be followed in the sample period, an exspected average of three days
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Organ Dysfunctions
Aikaikkuna: Participants will be followed in the sample period, an exspected average of three days
|
Participants will be followed in the sample period, an exspected average of three days
|
|
|
Concomitant medication
Aikaikkuna: Participants will be followed in the three postoperative days sample period
|
Concomitant medications from Anticholinergic Drug Scale (ADS)
|
Participants will be followed in the three postoperative days sample period
|
|
Postoperative Pain
Aikaikkuna: Participants will be followed in the three postoperative days sample period
|
According to Numeric Rating Scale
|
Participants will be followed in the three postoperative days sample period
|
|
Duration of Intensive Care Unit Stay
Aikaikkuna: Participants will be followed in the sample period, an exspected average of seven days
|
Participants will be followed in the sample period, an exspected average of seven days
|
|
|
Duration of Hospital Stay
Aikaikkuna: Participants will be followed in the sample period, an exspected average of four weeks
|
Participants will be followed in the sample period, an exspected average of four weeks
|
|
|
Duration of Mechanical Ventilation
Aikaikkuna: Participants will be followed in the sample period, an exspected average of 168 hours
|
Participants will be followed in the sample period, an exspected average of 168 hours
|
|
|
Readmission rate
Aikaikkuna: Participants will be followed in the sample period, an exspected average of four weeks
|
Participants will be followed in the sample period, an exspected average of four weeks
|
|
|
Hospital Treatment Data
Aikaikkuna: Participations will be followed for the duration of the operation day, an exspected time average of eight hours
|
Operation time, surgery, anaesthesia
|
Participations will be followed for the duration of the operation day, an exspected time average of eight hours
|
|
Postoperative Mortality
Aikaikkuna: Participants will be followed for the duration of the sample period an exspected average of five years
|
Mortality (measured inhouse-mortality according to the patients´records and based on the data record according to §21 Krankenhausentgeltgesetz - (KHEntgG))
|
Participants will be followed for the duration of the sample period an exspected average of five years
|
|
Postoperative Delirium
Aikaikkuna: Participants will be followed in the sample period, an exspected average of five years
|
Postoperative Delirium (measured by Diagnosis of Delirium according to the patients´records and based on the data record according to §21 Krankenhausentgeltgesetz -(KHEntgG))
|
Participants will be followed in the sample period, an exspected average of five years
|
|
Comorbidities
Aikaikkuna: Participants will be followed in the sample period, an exspected average of five years
|
Comorbidities based on the data record according to §21 Krankenhausentgeltgesetz - (KHEntgG)
|
Participants will be followed in the sample period, an exspected average of five years
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Opintojohtaja: Claudia Spies, MD, Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin
Julkaisuja ja hyödyllisiä linkkejä
Yleiset julkaisut
- Muller A, Olbert M, Heymann A, Zahn PK, Plaschke K, von Dossow V, Bitzinger D, Barth E, Meister M, Kranke P, Herrmann C, Wernecke KD, Spies CD. Relevance of peripheral cholinesterase activity on postoperative delirium in adult surgical patients (CESARO): A prospective observational cohort study. Eur J Anaesthesiol. 2019 Feb;36(2):114-122. doi: 10.1097/EJA.0000000000000888.
- Michels B, Holzamer A, Graf BM, Bredthauer A, Petermichl W, Muller A, Zausig YA, Bitzinger DI. Butyrylcholinesterase as a perioperative complication marker in patients after transcatheter aortic valve implantation: a prospective observational study. BMJ Open. 2021 Jul 6;11(7):e042857. doi: 10.1136/bmjopen-2020-042857.
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Arvio)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- CESARO
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .